Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
14,21 USD | -2,20% | -1,93% | -5,27% |
15/04 | UroGen Pharma zegt dat FDA Investigational New Drug Application voor potentiële behandeling van blaaskanker accepteert | MT |
15/03 | UROGEN PHARMA LTD. : Oppenheimer herhaalt koopadvies | ZM |
Vakgebied
Aantal werknemers: 200
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
RTGel Reverse-Thermal Hydrogel
100,0
%
| 64 | 100,0 % | 83 | 100,0 % | +28,52% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 64 | 100,0 % | 83 | 100,0 % | +28,52% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 62 | 03-01-19 | |
Dong Kim
DFI | Director of Finance/CFO | 47 | 01-08-21 |
Jason Smith
CMP | Compliance Officer | 52 | 09-09-20 |
Marina Konorty
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-11 |
Moran Mieron
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Mark Schoenberg
CTO | Chief Tech/Sci/R&D Officer | 66 | 09-02-16 |
Investor Relations Contact | - | 01-01-22 | |
Polly Murphy
PRN | Corporate Officer/Principal | 59 | 09-09-20 |
Jeff Bova
PRN | Corporate Officer/Principal | - | 01-01-17 |
James Ottinger
LAW | General Counsel | - | 01-10-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Arie Belldegrun
CHM | Chairman | 74 | 01-10-12 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 01-10-17 |
Fred Cohen
BRD | Director/Board Member | 67 | 16-05-17 |
Stuart Holden
BRD | Director/Board Member | 82 | 01-12-15 |
Chief Executive Officer | 62 | 03-01-19 | |
James Robinson
BRD | Director/Board Member | 54 | 25-07-23 |
Daniel Wildman
BRD | Director/Board Member | 68 | 08-11-22 |
Leana Wen
BRD | Director/Board Member | 41 | 12-09-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 34 122 087 | 30 249 041 ( 88,65 %) | 0 | 88,65 % |
Bedrijfsgegevens
UroGen Pharma Ltd.
400 Alexander Park Drive 4th floor
08540, Princeton
+(646) 768-9780
http://www.urogen.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,27% | 496 mln. | |
-1,51% | 105 mld. | |
+3,22% | 97,5 mld. | |
+1,86% | 22,19 mld. | |
-16,53% | 21,33 mld. | |
-8,49% | 18,68 mld. | |
-42,33% | 16,6 mld. | |
-20,09% | 14,52 mld. | |
+5,47% | 14,09 mld. | |
+28,85% | 10,99 mld. |
- Beurs
- Aandelen
- Koers URGN
- Onderneming UroGen Pharma Ltd.